“…The results from other studies are diverse, Harewood et al reported that the adverse events did not diminish over time and Fukatsu et al reported an increase from 10 % to 16 % (• " Table 3) [2,11,15,19]. On the other hand, Robinson et al reported a decrease in adverse events over time, which may be explained by the increased use of pancreatic stents in the latter groups (• " Table 3) [16,17,20,21]. One may argue that the nonexistence of a clear decline in the complication rates results from the use of precut only after a difficult biliary cannulation.…”